Mr. Zdzislaus Joseph Wanski, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1150 State Hwy 248 Suite 102, Branson, MO 65616 Phone: 417-348-8990 Fax: 417-348-8090 |
Mrs. Anju Susan Prasad, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 121 Cahill Rd Ste 201, Branson, MO 65616 Phone: 417-348-8990 Fax: 417-348-8090 |
News Archive
Research by George Mason University College of Health and Human Services found that adults who likely had undiagnosed celiac disease had lower bone density than the adults without UCD, although they consumed more calcium and phosphorous.
Age is not an independent factor in cancer survival rates and should not influence decisions about how to treat older patients, according to a study in the November issue of IJCP, the Independent Journal of Clinical Practice.
An international team of researchers led by a Fred Hutchinson Cancer Research Center geneticist has discovered two genes linked to a disabling form of arthritis called ankylosing spondylitis, a painful and progressive disease in which some or all of the spine's vertebrae fuse together.
Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.
SillaJen, Inc., a private, clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, has announced the initiation of a multinational randomized Phase 3 open-label study of its lead product candidate, Pexa-Vec (formerly JX-594), in patients with advanced liver cancer, also known as hepatocellular carcinoma (HCC).
› Verified 3 days ago